Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportPoster - Educational Exhibits

The Role of PET in Differentiation of Recurrent Brain Tumor from Radiation Injury

Shadi Asadollahi, Mona-Elisabeth Revheim, Thomas Werner and Abass Alavi
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 2024;
Shadi Asadollahi
1University of Penslyvania Health Systems Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mona-Elisabeth Revheim
2Oslo University Hospital Oslo Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Werner
3Hospital of the University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
4University Hospital of PA Wynnewood PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2024

Objectives: 1) Clarify efficacy and usefulness of FDG-PET for differentiating recurrent tumor from radiation necrosis 2) Compare FDG-PET with alternative modalities and techniques for this purpose3) Discuss the mechanism by which glucose metabolism take place in brain tumor and radiation injuries. Abstract (summary): The incidence of primary intracranial tumors is 7-19 cases per 100,000 people annually. There is an extensive diversity of pathologic subtypes, with gliomas accounting for 45% of all brain tumors. The general strategy for treating brain tumors is surgical resection of solitary lesions in combination with radiation therapy with or without chemotherapy. However, radiation may cause damage to vascular endothelial cells and oligodendrocytes leading to necrosis, axonal swelling, and reactive gliosis. This complication is the major dose-limiting complication of radiotherapy arising months to years after treatment. The consequent clinical manifestations include personality changes, dementia, memory deficits, seizures, and motor impairments. Unfortunately, these symptoms are similar to the recurrence of the brain tumor. Distinguishing between recurrence and radionecrosis is essential in directing therapy. The gold standard method is the biopsy of the lesion which is invasive and can cause severe complications. Other tools like computed tomography (CT) and standard magnetic resonance imaging (MRI) have not been able to reliably distinguish recurrent tumors from radiation-induced changes because both lesions demonstrate increased volume of enhancement, edema, and mass effect. Thus, there is a need for a more reliable clinical tool to overcome this lack of specificity. The use of functional fluorodeoxyglucose-positron emission tomography (FDG-PET) to distinguish recurrent tumor from radionecrosis appeared to be promising. It is known that tumor cells change glucose metabolism due to an increased dependence on anaerobic glycolysis. It was also known that successful radiation treatment resulted in a decreased FDG uptake over time and that tumor necrosis had not FDG uptake. Thus, it was hypothesized that evaluation of glucose consumption can differentiate recurrent tumor from radiation-induced changes. To further clarify this critical function, we aimed to discuss different aspects of PET in differentiation of recurrent brain tumor from radiation injury.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Role of PET in Differentiation of Recurrent Brain Tumor from Radiation Injury
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Role of PET in Differentiation of Recurrent Brain Tumor from Radiation Injury
Shadi Asadollahi, Mona-Elisabeth Revheim, Thomas Werner, Abass Alavi
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 2024;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Role of PET in Differentiation of Recurrent Brain Tumor from Radiation Injury
Shadi Asadollahi, Mona-Elisabeth Revheim, Thomas Werner, Abass Alavi
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 2024;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - Educational Exhibits

  • How Pathology Affects Appearance, Features of Invasive Lobular Carcinoma That Every Imaging Physician Should Know
  • FDG-PET/CT as the gold standard in assessing recovery of pulmonary function in COVID-19
  • A Pictorial Essay of Non Embolic Findings on VQ SPECT
Show more Poster - Educational Exhibits

Neurosciences

  • PET quantifies target engagement of MAGL therapeutics for Alzheimer’s disease
  • COVID-19 anosmia pathogenesis based on 18F-FDG PET studies
  • CSF Shunt Scintigraphy - spills and stops, review of protocols via challenging cases
Show more Neurosciences

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire